BONEH — BBS-Bioactive Bone Substitutes Oyj Share News
0.000.00%
Brief: BBS Files For Bankruptcy
Brief: Penalty Payment Has Been Imposed On BBS' Board Members
Brief: BBS CEO Juliusz Rakowski Terminates CEO Agreement
Brief: BBS Resolves On Temporary Layoffs
Brief: BBS Prepares For Supplementary Clinical Trial, To Evaluate Financial Situation
Brief: BBS Resolves On Share Issue Without Consideration To Itself
Brief: BBS To Start Change Negotiations
Brief: BBS Resolves On Share Issue
Brief: BBS Receives Complementary Patent For Artebone In USA
Brief: BBS-Bioactive Bone Substitutes Arranges Rights Offering Of About Maximum EUR 2.4 Mln
Brief: Bbs-Bioactive Bone Substitutes H1 Loss Widens To EUR 1.7 Mln
Brief: Bbs-Bioactive Bone Substitutes Resolves On Share Issue
Brief: BBS Plans Issue Of Up To 11,000,000 Shares
Claims Of Complementary Patent Application For Artebone Product Have Been Approved In US
Brief: BBS-Bioactive Bone Substitutes Appoints Annastiina Kauppinen As Financial Manager
Brief: BBS: Website's Functionality Restored
Brief: BBS's Public Websites Under Attack
Brief: BBS Changes At CFO Position
Brief: BBS Expects Commercial Operations To Begin At End Of Second Half Of 2024